Bio-Techne Corp. (TECH) News
Latest headlines that mention TECH, newest first · each headline opens the original publisher
- Last price
- $72.62
- Day change
- -0.03%
- Next earnings
- 2026-11-04
TECH headlines
latest coverageOn June 25, 2026, investors tracked deal progress as Bio-Techne shares responded to the proposed buyout terms.
Germany's Merck KGaA pledged Thursday to buy Bio-Techne for $11.3 billion. The deal expands its portfolio of life sciences tools. The post Germany's Merck KGaA Swoops In With $11.3 Billion Medtech Buyout appeared first on Investor's Business Daily .
Activist investor Ananym Capital Management has built a stake in Bio-Techne Corp. and is pushing the board to conduct a strategic review that would include a potential sale.
TECH news alerts
Get an alert by email or push when a new headline mentions TECH.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.